Next Generation Sequencing (NGS) Market worth $8.7 Billion by 2020 - New Report by MarketsandMarkets

Share Article

The NGS platforms market will be dominated by Illumina in 2014, which will occupy the largest market share of 74%. http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

MarketsandMarkets

MarketsandMarkets

Pacific Biosciences (U.S.). The NGS bioinformatics/data analysis market is dominated by players like CLC bio (Denmark) (acquired by QIAGEN), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.)

The “Next Generation Sequencing (NGS) Market by Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT), Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020”, analyses and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and Rest of World.

Get Detail Report From Here @ http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

Early buyers will receive 10% customization on this report.

International market ngs will be worth $2.5 billion by the end of 2014 and is poised to reach $ 8.7 billion by 2020 at a CAGR of 20.0% over. This report examines the global market hangs over the forecast period of 2014-2020.

The report covers market and clinical observations, genomics, applications, including drug discovery and proteomics. Despite major research institutions and studies that serve as key end-user market for ngs, hangs a recent technology being developed for use in clinical set-ups and a lot of effort now hangs is targeting cancer.

Next Generation Sequencing makes great growth market worldwide due to factors such as reducing costs, improving turnaround time, a growing number of applications, and instead of microarray applications and hangs. Key players are focusing on providing innovative products that are technologically advanced. Due to this, companies focus on cooperation, collaboration, new product launches and acquisitions in order to achieve a leadership position in the market

For Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=546

Sequencing by synthesis technology, occupies the highest market share, will be the fastest growing technology in the coming years. Growth will be driven platforms, such as HiSeq X Diez, NextSeq500 and MiSeq. Also has wide application in the market in NGS SBS technology, and can be used to read a single side library and torque. However, nanopore technology will change the face of the market, once introduced to the market. Companies such as Roche (Genia technology) and Oxford nanopore technology is studying the technology NGS. Nanopores expected to be released by the end of 2016 or 2017 have been launched in the market, is expected to cost about 500 yuan down sequencing.

Targeted resequencing, RNA sequencing and exome sequencing are the three main applications of NGS, mainly due to its low cost, to save time. These segemnets also will grow rapidly in the coming years in the first three segments.

Another important market revenue will NGS services market is expected to grow 24.0 percent in 2020, a compound annual growth rate can be attributed to diagnostic and pharmaceutical / biotech industry's growing demand. In the case of driving the diagnostic will increase in tumor growth and neonatal morbidity. Additionally, you may be reimbursed by the NGS diagnostics also boosted the market for 2015 implementation.

The global NGS market is highly consolidated with top two players, Illumina and Thermo Fisher (Life Technologies) occupying more than 90% of the pie (2013). Illumina led the market with its flagship NGS platforms such as HiSeq Series, GA IIx, and MiSeq. In 2014, it launched two new platforms HiSeq X Ten and NextSeq 500 which are poised to grow at CAGR of more than 20% in the coming years.

Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=546

The NGS data analysis market includes the market by product (software and services) and by applications such as whole genome sequencing, exome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. Some of the major applications of NGS include diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research.

The significant players adopting this strategy include Illumina, Inc (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc (U.S.), Pacific Biosciences (U.S.), DNASTAR, INC (U.S.), 454 Life Sciences Corporation (U.S.), PerkinElmer, Inc (U.S.), GATC Biotech AG (Germany) and CLC bio (a member of QIAGEN).

Browse Related Reports:
Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application

(Forensics, Paternity Testing), DNA Amplification, Quantification, Extraction, Services, & Software - Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/human-identification-market-100607777.html

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips,

Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at: http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn at: http://www.linkedin.com/company/marketsandmarkets

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
Like >
Follow us on
Visit website